PepJunkie Home of the Peptonauts
More

Peptide Atlas · Vitamin

Riboflavin

In a three-month randomized trial in 55 people with migraine, high-dose riboflavin (400 mg a day) reduced attack frequency and headache days more than placebo, with 59% responders against 15%.

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

    • emerging
      Claim: High-dose riboflavin for migraine prophylaxis (RCT, n=55) standing
    • resolved

    Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.

    Schoenen J, Jacquy J, Lenaerts M

    pmid 9484373

    • preclinical
      Claim: Riboflavin-UVA cross-linking increases corneal rigidity (ex vivo) standing
    • resolved

    Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking.

    Wollensak G, Spoerl E, Seiler T

    pmid 14522301

A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.